Transportadora de Gas del Sur S.A. (ADR) (NYSE:TGS) announced on Monday the results of the exchange offer in relation to the USD 374 million principal amount of its 7.875% guaranteed senior unsecured notes due 2017 (the “old notes”). The offer reached a 67% acceptance level resulting in approximately USD 250 million of debt exchanged out of the USD 374 million of old notes outstanding. Transportadora de Gas del Sur SA (ADR) (NYSE:TGS) shares after opening at $2.61 moved to $2.75 on last trade day and at the end of the day closed at $2.73. Company price to sales ratio in past twelve months was calculated as 0.72. Transportadora de Gas del Sur SA (ADR) (NYSE:TGS) showed a positive weekly performance of 2.62%.
Tesco Corporation (USA) (NASDAQ:TESO) posted its quarterly earnings results on Monday. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by $0.04, Analyst Ratings.Net reports. The company had revenue of $121.40 million for the quarter, compared to the consensus estimate of $137.52 million. Tesco Corporation (USA) (NASDAQ:TESO) shares advanced 6.13% in last trading session and ended the day on $20.60. TESO return on equity ratio is recorded as 12.90% and its return on assets is 10.60 %. Tesco Corporation (USA) (NASDAQ:TESO) yearly performance is 62.08%.
Anacor Pharmaceuticals Inc (NASDAQ:ANAC) Announces First Quarter 2014 Financial Results Conference Call and Webcast. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the first quarter ended March 31, 2014, on Wednesday, May 7, 2014 at approximately 4:00 p.m. ET / 1:00 p.m. PT. Anacor Pharmaceuticals Inc (NASDAQ:ANAC) shares moved up 6.26% in last trading session and was closed at $17.65 while trading in range of $16.28 – $17.87 – Anacor Pharmaceuticals Inc (NASDAQ:ANAC) year to date (YTD) performance is 5.18%.
XOMA Corporation (NASDAQ:XOMA) a leader in the discovery and development of antibody therapeutics, announced the Company will host a conference call on Wednesday, May 7, 2014, at 4:30 p.m. Eastern time to discuss first quarter 2014 financial results and provide an update on gevokizumab’s global clinical programs. XOMA Corp (NASDAQ:XOMA) weekly performance is 21.73%. On last trading day company shares ended up $4.65. XOMA Corp (NASDAQ:XOMA) distance from 50-day simple moving average (SMA50) is -18.59%. Analysts mean target price for the company is $9.25.
Leave a Reply